549 filings
8-K
CRVO
CervoMed Inc
14 Dec 20
Regulation FD Disclosure
11:32am
4
Cobuzzi Robert Joseph Jr.
18 Nov 20
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
9:15pm
4
CRVO
CervoMed Inc
18 Nov 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
8:33am
10-Q
2020 Q3
CRVO
CervoMed Inc
Quarterly report
12 Nov 20
5:28pm
8-K
CRVO
CervoMed Inc
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
4
5wpc2rexqf tond
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
8:04pm
3
jnpdgj0m4ghh27h
21 Oct 20
Diffusion Pharmaceuticals / CHRISTOPHER D GALLOWAY ownership change
7:49pm
8-K
qcwqsemdqccuuc9 hc6
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
4
ma3cezkkpfws
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:40pm
3
4h9b0ut9jl 8yt4dj2fa
14 Oct 20
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:27pm
8-K
z6e2 lsp7dt
9 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
EFFECT
l5qisiilvojvvyp5dk
5 Oct 20
Notice of effectiveness
12:21am
424B2
xt8ebi zrn2hq461dqz1
2 Oct 20
Prospectus for primary offering
4:16pm
4
7i5tah
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:29pm
3
ot1x 15zk
1 Oct 20
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:22pm
CORRESP
4ht9wdw314rxcap5gbm
30 Sep 20
Correspondence with SEC
12:00am
UPLOAD
5nk ie2qdf
29 Sep 20
Letter from SEC
12:00am
8-K
9mg47y1qps
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
a25pb0fkv kz0snxy
15 Sep 20
Regulation FD Disclosure
2:50pm